ELLEN KARWACKI: Open Payments
NPI 1083604938 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 31 payments from 8 companies in 2025. Trend: 2023 $1,683 · 2024 $572 · 2025 $1,386
Food & beverage: $1,386
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $430 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $299 |
| Alkermes, Inc. | 3 | $257 |
| E.R. Squibb & Sons, L.L.C. | 4 | $146 |
| Neurocrine BioSciences, Inc. | 3 | $91 |
| Vanda Pharmaceuticals Inc. | 1 | $83 |
| ABBVIE INC. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: INVEGA SUSTENNA, CAPLYTA, COBENFY, LYBALVI, ARISTADA, INGREZZA, FANAPT, VRAYLAR.
Industry payments across NY — which companies pay providers there.
